Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma.

Li, Bao-sheng

Phase I study of concurrent selective lymph node late course accelerated hyper-fractionated radiotherapy and Capecitabine, Cisplatin for locally advanced esophageal squamous cell carcinoma. [electronic resource] - Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology Dec 2009 - 458-61 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

1879-0887

10.1016/j.radonc.2009.08.002 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Capecitabine
Carcinoma, Squamous Cell--drug therapy
Cisplatin--administration & dosage
Combined Modality Therapy
Deoxycytidine--administration & dosage
Dose Fractionation, Radiation
Esophageal Neoplasms--drug therapy
Female
Fluorouracil--administration & dosage
Humans
Lymphatic Irradiation
Lymphatic Metastasis
Male
Middle Aged
Radiation Injuries
Radiotherapy Dosage
Radiotherapy, Intensity-Modulated
Survival Rate